What does ACORN CAPITAL ADVISORS, LLC hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

ACORN CAPITAL ADVISORS, LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

TERNS PHARMACEUTICALS INC

$92M1.7M26.2%

CG ONCOLOGY INC

$77M1.1M21.8%

UROGEN PHARMA LTD

$30M1.7M8.6%

PUMA BIOTECHNOLOGY INC

$26M4.1M7.5%

TREVI THERAPEUTICS INC

$26M2.1M7.3%

CANDEL THERAPEUTICS INC

$17M3.5M4.9%

BICARA THERAPEUTICS

$13M643K3.6%

ONKURE THERAPEUTICS INC

$12M2.8M3.3%

JADE BIOSCEINCES INC

$11M787K3.1%

PROTARA THERAPEUTICS INC

$9M1.8M2.6%

Filing history loading…